Predicate |
Object |
contentType |
Journal Article |
endingPage |
e2274 |
issn |
0959-8138 1468-5833 |
issueIdentifier |
mar22 2 |
pageRange |
e2274-e2274 |
publicationName |
BMJ (Clinical research ed.) |
startingPage |
e2274 |
bibliographicCitation |
Wise J. NICE backs leukaemia drug after manufacturer drops price. BMJ. 2012 Mar 22;344():e2274. doi: 10.1136/bmj.e2274. PMID: 22442356. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_375fbedec50a31e41b3e2e941eb122e4 |
date |
2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/22442356 https://doi.org/10.1136/bmj.e2274 |
isPartOf |
https://portal.issn.org/resource/ISSN/0959-8138 https://portal.issn.org/resource/ISSN/1468-5833 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2274 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
NICE backs leukaemia drug after manufacturer drops price |
discusses |
http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0482811 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0016884 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000970Q000191 http://id.nlm.nih.gov/mesh/D015464Q000191 http://id.nlm.nih.gov/mesh/D011743Q000627 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D013844Q000627 http://id.nlm.nih.gov/mesh/D003362 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D006113 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D017410 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D011743Q000191 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D010879Q000191 http://id.nlm.nih.gov/mesh/D006801 |